GSK Ad Campaign Highlights R&D Investment, “Orange Card”
Executive Summary
GlaxoSmithKline is highlighting its investment in R&D in a national advertising campaign
You may also be interested in...
Rx Industry Image Fix Will Take More Than Ads, CEOs Say; Is Unity A Risk?
Image advertising is not enough to help rebuild the pharmaceutical industry's public image, AstraZeneca CEO Tom McKillop declared during the Pharmaceutical Leadership Forum Nov. 16 in Washington, D.C
Rx Industry Image Fix Will Take More Than Ads, CEOs Say; Is Unity A Risk?
Image advertising is not enough to help rebuild the pharmaceutical industry's public image, AstraZeneca CEO Tom McKillop declared during the Pharmaceutical Leadership Forum Nov. 16 in Washington, D.C
GSK Sales Reps Speaking Out Against Rx Importation In Grassroots Effort
GlaxoSmithKline is using its pharmaceutical sales force to advance the company's agenda against drug importation in an attempt to curb growing support for a U.S.-sanctioned policy